Bullous subacute cutaneous lupus erythematosus

Clinical and Experimental Dermatology

Volumn 29, Issue 3, 2004, Pages 265-267

  Perera, G K ^a,b   Black, M M ^a   McGibbon, D H ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

^b KING S COLLEGE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; DOXORUBICIN;

ADULT; ALOPECIA; ANAMNESIS; AUTOIMMUNE DISEASE; BULLOUS SKIN DISEASE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CASE REPORT; CLINICAL FEATURE; DISEASE EXACERBATION; EPIDERMOLYSIS; ERYTHEMA MULTIFORME; FEMALE; HUMAN; HUMAN TISSUE; LEIOMYOSARCOMA; MEDICAL EXAMINATION; PHOTOSTIMULATION; PRIORITY JOURNAL; RASH; RECURRENT DISEASE; REVIEW; SKIN BIOPSY; SKIN LUPUS ERYTHEMATOSUS; SYMPTOM; UTERUS TUMOR; WOUND DRESSING;

ANTINEOPLASTIC AGENTS; BLISTER; DIAGNOSIS, DIFFERENTIAL; DRUG ERUPTIONS; EPIDERMAL NECROLYSIS, TOXIC; ERYTHEMA MULTIFORME; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, CUTANEOUS; MIDDLE AGED; PHOTOSENSITIVITY DISORDERS; SUNLIGHT;

EID: 2442694197     PISSN: 03076938     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2230.2004.01498.x     Document Type: Review

References (12)

1. Sontheimer RD, Thomas JR, Gilliam JN. Subacute cutaneous lupus erythematosus: a cutaneous marker for a distinct lupus erythematosus subset. Arch Dermatol 1979; 115: 1409-15.
2. Norris DA. Pathogenesis of cutaneous lupus: pathomechanisms of photosensitive lupus erythematosus. J Invest Dermatol 1993; 100 (Suppl.): 58S-68S.
3. Solberg LA, Wick MR, Bruckman JE. Doxorubicin-enhanced skin reaction after whole-body electron-beam irradiation for leukaemia cutis. Mayo Clin Proc 1980; 55: 711-5.
4. Rowell NR, Beck SJ, Anderson JR. Lupus erythematosus and erythema multiforme-like lesions. Arch Dermatol 1963; 88: 176-80.
5. Brenner S, Golan H, Gat A, Bialy-Golan A. Paraneoplastic subacute cutaneous lupus erythematosus: report of a case associated with cancer of the lung. Dermatology 1997; 194: 172-4.
6. Anhalt GJ, Kim SC, Stanley JR et al. Paraneoplastic pemphigus: an autoimmune mucocutaneous disease associated with neoplasia. N Engl J Med 1990; 323: 1729-35.
7. Mandelcorn R, Shear NH. Lupus-associated toxic epidermal necrolysis: a novel manifestation of lupus? J Am Acad Dermatol 2003; 48: 525-9.
8. Bielsa I, Herrero C, Font J, Mascaro JM. Lupus erythematosus and toxic epidermal necrolysis. J Am Acad Dermatolo 1987; 16: 1265-7.
9. Mutasim DF. Severe subacute cutaneous lupus erythematosus presenting with generalised erythroderma and bullae. J Am Acad Dermatol 2003; 48: 947-9.
10. Werth VP, Zhang W, Dortzbach K, Sullivan K. Association of a promoter polymorphism of tumour necrosis factor-a with subacute cutaneous lupus erythematosus and distinct photoregulation of transcription. J Invest Dermatol 2000; 115: 726-30.
11. Ehrenfeld M, Abu-Shakra M, Buskila D, Shoenfeld Y. The dual association between lymphoma and autoimmunity. Blood Cells, Molecules Dis 2002; 27: 750-6.
12. Pichler WJ, Yawalker N, Britschgi M et al. Cellular and molecular pathophysiology of cutaneous drug reactions. Am J Clin Dermatol 2002; 3: 229-38.